Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. [electronic resource]
Producer: 20070802Description: H2729-36 p. digitalISSN:- 0363-6135
- Acetophenones -- pharmacology
- Animals
- Blood Flow Velocity
- Cells, Cultured
- Collateral Circulation -- drug effects
- Coronary Circulation -- drug effects
- Coronary Vessels -- surgery
- Disease Models, Animal
- Ditiocarb -- pharmacology
- Endothelial Cells -- drug effects
- Enzyme Inhibitors -- pharmacology
- Humans
- Imidazoles -- pharmacology
- Ligation
- MAP Kinase Signaling System -- drug effects
- Male
- Myocardial Reperfusion Injury -- enzymology
- NADPH Oxidases -- antagonists & inhibitors
- Neovascularization, Physiologic
- Onium Compounds -- pharmacology
- Oxygenases -- antagonists & inhibitors
- Pyridines -- pharmacology
- Rats
- Rats, Inbred WKY
- Reactive Oxygen Species -- metabolism
- Superoxide Dismutase -- antagonists & inhibitors
- Vascular Endothelial Growth Factor A -- metabolism
- p38 Mitogen-Activated Protein Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.